重症COVID-19呼吸衰竭的原地肺动脉溶栓与灌注肺血管造影
这项前瞻性、开放标签、同情用药的概念验证研究在墨西哥General Hospital Dr Eduardo Liceaga的单一COVID-19 ICU纳入15例18-75岁重症Delta变异株SARS-CoV-2感染患者,均需机械通气且持续FiO2≥70%、PaO2/FiO2(或推算比值)<150超过4小时,凝血纳入标准为ISTH评分>5、D-二聚体>1200且ROTEM显示高凝(EXTEM 5分钟振幅>65、FIBTEM>30)伴低纤溶(EXTEM最大溶解<8%)。干预为导管导向tPA血管造影及iFlow系统分析,评估溶栓前后肺灌注变化。9例造影显示微血管充盈缺损,与iFlow分析一致性良好(ƙ=0.714);有与无充盈缺损的2期DM感兴趣区AUC/参考组织AUC差异有统计学意义(-0.09206,sd±0.16684,p=0.003);术后即刻和48小时PaO2/FiO2显著升高(p=0.001和p=0.005),D-二聚体(p=0.007)、FiO2(p=0.002)、SpO2/FiO2(p=0.045)及术前、术后即刻、术后48小时需要俯卧位通气的患者数(p=0.002)差异均有统计学意义。结论认为导管导向tPA溶栓后肺动脉造影和iFlow技术提供了肺灌注改善的影像学证据。
要点
- 纳入15例重症Delta变异株COVID-19呼吸衰竭患者,需机械通气且持续FiO2≥70%、PaO2/FiO2(或推算比值)<150超过4小时。
- 凝血纳入标准为ISTH评分>5、D-二聚体>1200,ROTEM显示高凝(EXTEM 5分钟振幅>65、FIBTEM>30)伴低纤溶(EXTEM最大溶解<8%)。
- 9例患者造影显示微血管充盈缺损,与iFlow分析一致性良好(ƙ=0.714)。
- 术后即刻和48小时PaO2/FiO2较术前显著升高(p=0.001和p=0.005)。
- D-二聚体(p=0.007)、FiO2(p=0.002)、SpO2/FiO2(p=0.045)及需要俯卧位通气的患者数(p=0.002)在术前、术后即刻和48小时差异有统计学意义。
适用人群与场景
- 18-75岁重症Delta变异株SARS-CoV-2感染患者,需机械通气,持续FiO2≥70%且PaO2/FiO2(或推算比值)<150超过4小时。
- 凝血纳入标准:ISTH评分>5、D-二聚体>1200,ROTEM显示高凝(EXTEM 5分钟振幅>65、FIBTEM>30)伴低纤溶(EXTEM最大溶解<8%)。
- 场景:墨西哥General Hospital Dr Eduardo Liceaga的单一COVID-19 ICU。
诊断标准与关键阈值
- 重症呼吸衰竭:机械通气下持续FiO2≥70%且PaO2/FiO2(或推算比值)<150超过4小时。
- 凝血纳入标准:ISTH评分>5、D-二聚体>1200,ROTEM显示高凝(EXTEM 5分钟振幅>65、FIBTEM>30)伴低纤溶(EXTEM最大溶解<8%)。
处置流程与药物剂量
- 导管导向tPA溶栓联合肺动脉造影及iFlow系统分析,评估溶栓前基线肺灌注及溶栓后灌注变化。
研究设计与关键结果
- 前瞻性、开放标签、同情用药概念验证研究,单中心(墨西哥General Hospital Dr Eduardo Liceaga的COVID-19 ICU),纳入15例重症Delta变异株COVID-19呼吸衰竭机械通气患者。
- 9例患者血管造影显示微血管充盈缺损,与iFlow分析一致性良好(ƙ=0.714)。
- 有与无充盈缺损的2期DM感兴趣区AUC/参考组织AUC差异有统计学意义:-0.09206(sd±0.16684),p=0.003。
- 术后即刻和48小时PaO2/FiO2较术前显著升高(p=0.001和p=0.005)。
- D-二聚体(p=0.007)、FiO2(p=0.002)、SpO2/FiO2(p=0.045)以及术前、术后即刻、术后48小时需要俯卧位通气的患者数(p=0.002)差异有统计学意义。
证据类型、等级与局限
- 证据类型:前瞻性、开放标签、同情用药概念验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,导管导向tPA溶栓后肺动脉造影和iFlow技术可提供重症COVID-19呼吸衰竭患者肺灌注改善的影像学证据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: A proof-of-concept study using thrombolysis with catheter-directed tissue plasminogen activator (tPA) and pulmonary angiography imaging was performed to visualize perfusion deficits and reperfusion/therapeutic effects of tPA.
DESIGN: A prospective, open-label, compassionate study. Descriptive statistics were presented for categorical variables and as means with sds for continuous variables. The Wilcoxon test was used to determine the differences between the two-related samples and a t test for continuous variables. Statistical significance was set at p value of less than 0.05. Agreement between observations was evaluated using the Kappa Cohen index and overall agreement using the Fleiss Kappa coefficient.
SETTING: A single COVID-19 ICU of Mexico´s General Hospital Dr Eduardo Liceaga.
SUBJECTS: Fifteen patients with severe Delta variant severe acute respiratory syndrome coronavirus 2 infection, 18-75 years old, requiring mechanical ventilation with a persistent Fio2 requirement of 70% or higher and Pao2/Fio2 ratio (or imputed ratio) less than 150 for more than 4 hours. The coagulation inclusion criteria were International Society on Thrombosis and Haemostasis score greater than 5, and presence of a d-dimer greater than 1,200, with viscoelastic testing using rotational thromboelastometry (Instrumentation Laboratories, Mexico City, Mexico) showing both hypercoagulability (EXTEM amplitude at 5 min > 65 FIBTEM > 30) and hypofibrinolysis (EXTEM maximum lysis < 8%).
INTERVENTIONS: Catheter-directed tPA angiography and iFlow system analysis to assess pre-tPA baseline pulmonary perfusion and changes in response to thrombolysis.
RESULTS: Nine patients had microvascular filling defects demonstrated by angiography, and good agreement was found with iFlow analysis (ƙ = 0.714). Statistically significant differences were identified in the area under the curve (AUC) region of interest/AUC reference tissue with and without filling defects in phase 2 DM -0.09206 (sd ± 0.16684) (p = 0.003). The Pao2/Fio2 values measured immediately and 48 hours after the procedure were significantly higher (p = 0.001 and p = 0.005, respectively). Statistically significant differences were found in d-dimer values (p = 0.007), Fio2 (p = 0.002), and oxygen saturation in arterial blood/Fio2 (p = 0.045), as well as in the number of patients who required prone positioning before, immediately after the procedure, and at 48 hours after the procedure (p = 0.002).
CONCLUSIONS: Thrombolysis with catheter-directed tPA resulted in imaging evidence via pulmonary angiography and iFlow technology of improved lung perfusion in COVID-19 patients with severe respiratory failure.
参考来源
- Pérez-Calatayud AA, Enriquez-García R, Fareli-González C, et al. In Situ Pulmonary Thrombolysis and Perfusion Lung Angiography in Severe COVID-19 Respiratory Failure. Crit Care Explor. 2022. PMID: 35372845. doi:10.1097/CCE.0000000000000670
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。